유럽 ​​심부 부분층 화상 치료 시장 규모, 점유율 및 동향 분석 보고서 – 산업 개요 및 2033년까지의 전망

유럽 ​​심부 부분층 화상 치료 시장 규모

• 유럽의 심부 부분층 화상 치료 시장 규모는 2025년 3,082억 9천만 달러 였으며, 예측 기간 동안 연평균 성장률(CAGR) 5.80% 로 성장하여 2033년에는 4,839억 9천만 달러  에 이를 것으로 예상됩니다  .
• 시장 성장은 전 세계적으로 화상 발생률이 증가하고, 첨단 상처 치료법에 대한 인식이 높아지고 있으며, 재생 의학 및 피부 복구 기술의 지속적인 기술 발전으로 병원 및 전문 화상 치료 센터 전반에 걸쳐 임상 결과가 개선되고 있는 데 크게 기인합니다.
• 더욱이, 효과적이고 빠른 회복을 촉진하며 감염에 강한 치료 솔루션에 대한 수요가 증가함에 따라, 첨단 드레싱, 생물학적 제제 및 피부 대체 요법이 심부 부분층 화상 관리의 선호되는 접근법으로 자리 잡고 있습니다. 이러한 여러 요인이 복합적으로 작용하여 심부 부분층 화상 치료 솔루션의 도입을 가속화하고 있으며, 이는 관련 산업의 성장을 크게 촉진하고 있습니다.

유럽 ​​심부 부분층 열화상 치료 시장 분석

• 심부 부분층 화상에 대한 고도의 치료법은 빠른 치유 촉진, 감염 위험 감소, 기능적 및 미용적 결과 개선 등의 효과로 인해 병원 및 전문 화상 치료 환경 모두에서 현대 의료 시스템의 필수적인 요소로 자리 잡고 있습니다.
• 이러한 치료법에 대한 수요 증가는 주로 화상 발생률 증가, 첨단 상처 관리법에 대한 인식 제고, 그리고 흉터를 최소화하고 입원 기간을 단축하는 생물학적 제제, 피부 대체재 및 재생 치료법에 대한 선호도 증가에 기인합니다.
• 영국은 잘 구축된 공공 의료 시스템, 첨단 상처 치료 제품의 높은 도입률, 전문 화상 치료 시설, 그리고 임상 연구 및 근거 기반 화상 관리 관행에 대한 지속적인 투자에 힘입어 2025년까지 심부 부분층 화상 치료 시장에서 32.4%의 가장 큰 매출 점유율을 기록하며 선두를 차지했습니다.
• 독일은 의료비 지출 증가, 혁신적인 피부 이식 및 생체 공학 드레싱의 빠른 도입, 외상 및 화상 센터 확장, 첨단 의료 기술에 대한 높은 관심에 힘입어 예측 기간 동안 심부 부분층 화상 치료 시장에서 가장 빠르게 성장하는 국가가 될 것으로 예상됩니다.
• 국소 도포제 부문은 화상 부위에 직접 적용할 수 있고 임상적 효과가 뛰어나다는 장점에 힘입어 2025년에는 전체 시장 매출의 59.3%를 차지하며 가장 큰 비중을 차지할 것으로 예상됩니다.

보고서 범위 및 심부 부분층 열화상 치료 시장 세분화  

유럽 ​​심부 부분층 화상 치료 시장 동향

생체공학적 피부 대체재 및 재생 치료의 발전

• A significant and accelerating trend in the global deep partial-thickness thermal burns treatment market is the increasing adoption of advanced wound care technologies, including bioengineered skin substitutes, regenerative biomaterials, and growth-factor-based therapies designed to accelerate healing and minimize scarring. These innovations are improving clinical outcomes while reducing hospitalization duration and long-term treatment costs worldwide
  • For instance, the growing global use of bioengineered skin substitutes such as Integra Dermal Regeneration Template and Matriderm across burn care centers is enabling faster tissue regeneration, improved wound closure outcomes, and reduced need for repeated surgical grafting procedures in patients with deep partial-thickness burns
• Technological advancements in hydrogel dressings, antimicrobial dressings, collagen matrices, and negative pressure wound therapy (NPWT) systems are further enhancing infection control, moisture balance, and tissue regeneration, making these solutions increasingly preferred treatment options across hospitals and specialized burn units globally
• In addition, increasing research focused on stem-cell-based regenerative therapies, platelet-rich plasma (PRP), and biomaterial scaffolds is expanding the pipeline of next-generation burn treatment solutions, particularly in developed healthcare markets across North America, Europe, and Asia-Pacific
• The growing adoption of standardized burn management protocols and multidisciplinary burn care approaches across global healthcare systems is further accelerating the integration of advanced treatment products specifically designed for partial-thickness burns
• As healthcare providers increasingly prioritize faster healing outcomes, reduced surgical interventions, and improved cosmetic recovery, the demand for advanced regenerative burn treatment solutions is expected to rise steadily worldwide

Europe Deep Partial-thickness Thermal Burns Treatment Market Dynamics

Driver

Rising Global Incidence of Burn Injuries and Expansion of Specialized Burn Care Infrastructure

• The increasing global incidence of burn injuries caused by industrial accidents, residential fires, occupational hazards, and road-related incidents is a major factor driving the demand for advanced deep partial-thickness thermal burn treatment solutions
  • For instance, the continuous expansion of specialized burn centers and trauma treatment facilities across countries such as the U.S., China, India, Germany, and Brazil has significantly increased the availability of advanced wound care therapies, supporting higher adoption of modern burn treatment products
• Growing government investments in emergency care infrastructure, trauma response systems, and critical care facilities are improving patient access to timely treatment, thereby strengthening demand for advanced dressings, biologics, and skin substitutes worldwide
• Furthermore, increasing awareness among healthcare professionals regarding early burn management, infection prevention, and advanced wound care protocols is encouraging the adoption of clinically advanced treatment strategies aimed at reducing complications and improving survival rates
• The rising number of reconstructive surgical procedures and skin grafting interventions related to burn injuries is also contributing to the growing demand for supportive wound care materials and regenerative treatment technologies across hospitals and specialty clinics globally
• Collectively, these factors are expected to significantly drive the growth of the deep partial-thickness thermal burns treatment market during the forecast period

Restraint/Challenge

High Treatment Costs and Limited Accessibility to Advanced Burn Care Therapies

• The high cost associated with advanced burn treatment solutions, including bioengineered skin substitutes, regenerative biologics, and specialized wound care products, remains a significant challenge limiting widespread adoption, particularly in low- and middle-income countries
  • For instance, advanced dermal regeneration templates and biologically engineered graft materials used in severe burn management can be several times more expensive than conventional dressings, creating affordability and reimbursement challenges for hospitals operating under constrained healthcare budgets
• In addition, limited availability of specialized burn care centers and trained burn care professionals in certain developing regions can delay access to advanced treatment options, affecting patient outcomes and slowing market penetration of innovative therapies
• Reimbursement complexities and variations in healthcare coverage policies across countries also create inconsistencies in the adoption of premium burn treatment technologies worldwide
• Furthermore, the requirement for specialized clinical expertise, controlled treatment environments, and advanced hospital infrastructure to administer certain regenerative therapies increases operational costs and implementation barriers
• Addressing these challenges through improved reimbursement frameworks, expansion of specialized burn care infrastructure, cost-effective product innovations, and global training initiatives for burn care professionals will be essential for ensuring sustained long-term market growth

Europe Deep Partial-thickness Thermal Burns Treatment Market Scope

The market is segmented on the basis of burn type, treatment, route of administration, end user, and distribution channel.

• By Burn Type

On the basis of burn type, the Deep Partial-thickness Thermal Burns Treatment market is segmented into fire burn injuries, scald burn, and hot objects. The fire burn injuries segment dominated the largest market revenue share of 44.6% in 2025, driven by the high incidence of flame-related injuries in industrial accidents, residential fires, and road traffic incidents. Fire burns often result in deeper tissue damage, requiring prolonged and intensive treatment. Increased urbanization and industrial activity raise exposure risks. Fire-related burns commonly necessitate advanced wound care products and surgical intervention. Hospitals report a higher admission rate for flame burns compared to other burn types. Government fire safety gaps in developing regions further contribute to prevalence. Severe pain and infection risks increase treatment demand. Advanced burn units focus significantly on fire burn cases. Longer hospital stays increase treatment costs and revenue contribution. Emergency response improvements increase survival, raising treatment needs. High clinical complexity sustains dominance. Strong reimbursement in developed regions supports revenue leadership.

The scald burn segment is expected to witness the fastest CAGR of 22.9% from 2026 to 2033, driven by rising domestic accidents involving hot liquids, especially among children and elderly populations. Increasing urban household density raises scald injury risks. Growing awareness and early diagnosis improve treatment rates. Pediatric burn cases significantly contribute to growth. Improved access to topical and advanced wound dressings supports recovery. Expansion of home healthcare services supports treatment outside hospitals. Rising use of minimally invasive therapies accelerates adoption. Public health campaigns promote early treatment. Shorter healing timelines encourage outpatient care. Increasing disposable income supports access to advanced therapies. Growing hospital reporting improves market capture. These factors drive rapid CAGR growth.

• By Treatment

On the basis of treatment, the Deep Partial-thickness Thermal Burns Treatment market is segmented into initial wound care, physical and occupational therapy, and others. The initial wound care segment dominated the market with a revenue share of 51.8% in 2025, driven by its critical role in preventing infection, minimizing tissue damage, and accelerating healing. Immediate wound cleaning, debridement, and dressing are essential for deep partial-thickness burns. Hospitals prioritize early intervention to reduce complications. Increased adoption of antimicrobial dressings supports dominance. Advanced wound care products improve patient outcomes. Higher hospital admission rates boost demand. Initial care determines long-term recovery success. Availability of standardized treatment protocols supports widespread use. Emergency departments account for high treatment volumes. Technological advancements improve effectiveness. Rising burn incidence sustains demand. Strong clinical necessity ensures dominance.

The physical and occupational therapy segment is projected to grow at the fastest CAGR of 21.6% from 2026 to 2033, driven by increasing focus on functional recovery and long-term rehabilitation. Burn survivors increasingly seek mobility restoration. Early rehabilitation improves quality of life. Growing awareness among clinicians promotes therapy inclusion. Expansion of rehabilitation centers supports access. Rising survival rates increase rehabilitation demand. Improved therapy techniques enhance outcomes. Increasing insurance coverage supports affordability. Home-based therapy adoption fuels growth. Digital rehabilitation tools improve monitoring. Pediatric and working-age patients drive demand. These factors collectively support strong CAGR growth.

• By Route of Administration

On the basis of route of administration, the Deep Partial-thickness Thermal Burns Treatment market is segmented into topical, oral, and others. The topical segment accounted for the largest market revenue share of 59.3% in 2025, driven by its direct application to burn wounds and high clinical effectiveness. Topical treatments provide localized infection control and pain relief. They promote faster epithelial regeneration. Widespread availability of creams, gels, and dressings supports adoption. Hospitals prefer topical agents for controlled delivery. Reduced systemic side effects favor dominance. Frequent reapplication increases consumption volume. Advanced silver-based and bioactive dressings strengthen demand. Easy administration supports outpatient care. Cost-effectiveness boosts accessibility. Strong clinician trust sustains usage. These factors reinforce market leadership.

The oral segment is expected to witness the fastest CAGR of 20.8% from 2026 to 2033, driven by increasing use of oral antibiotics and pain management therapies. Oral medications complement topical treatment. Rising infection management needs support growth. Improved drug formulations enhance efficacy. Increased outpatient treatment adoption supports demand. Patient preference for non-invasive therapy boosts usage. Expanding pharmaceutical availability supports access. Growing prescription rates increase consumption. Cost-effective oral therapies appeal to developing markets. Improved adherence supports outcomes. Expansion of retail pharmacies fuels distribution. This drives strong CAGR expansion.

• By End User

On the basis of end user, the Deep Partial-thickness Thermal Burns Treatment market is segmented into hospitals, specialty clinics, ambulatory surgical centers, home healthcare, and others. The hospitals segment dominated the market with a revenue share of 47.9% in 2025, driven by the availability of specialized burn care units and advanced infrastructure. Hospitals handle severe burn cases requiring surgery and intensive monitoring. High patient inflow supports revenue generation. Multidisciplinary teams improve outcomes. Emergency admission capability strengthens dominance. Access to advanced wound care technologies supports treatment complexity. Longer inpatient stays increase costs. Government-funded burn centers boost volume. Strong reimbursement frameworks support hospital care. Continuous training enhances treatment quality. High trust levels sustain patient preference. These factors ensure dominance.

The home healthcare segment is anticipated to grow at the fastest CAGR of 23.4% from 2026 to 2033, driven by rising preference for post-acute care at home. Advancements in portable wound care devices support growth. Reduced hospital burden encourages home treatment. Aging population increases demand. Cost-effectiveness supports adoption. Improved nursing services enhance care quality. Telemedicine integration improves monitoring. Rising outpatient recovery rates boost demand. Patient comfort drives preference. Insurance support improves accessibility. Expansion in urban home care services fuels growth. This results in rapid CAGR expansion.

• By Distribution Channel

On the basis of distribution channel, the Deep Partial-thickness Thermal Burns Treatment market is segmented into direct tender, hospital pharmacy, online pharmacy, retail pharmacy, and others. The hospital pharmacy segment held the largest market revenue share of 42.5% in 2025, driven by centralized procurement and immediate availability of burn treatment products. Hospitals rely on in-house pharmacies for critical care supplies. Bulk purchasing reduces costs. Controlled dispensing ensures patient safety. High inpatient volumes support dominance. Availability of specialized medications strengthens preference. Integration with treatment protocols improves efficiency. Strong inventory management supports reliability. Emergency access boosts utilization. Regulatory compliance supports trust. Skilled pharmacists improve outcomes. These factors maintain leadership.

The online pharmacy segment is expected to grow at the fastest CAGR of 24.1% from 2026 to 2033, driven by increasing digital healthcare adoption. Convenience and home delivery boost demand. Rising smartphone penetration supports access. Chronic burn care patients prefer repeat ordering online. Competitive pricing attracts users. Expansion of e-pharmacy platforms fuels growth. Improved logistics ensure timely delivery. Increased trust in digital prescriptions supports adoption. Growing home healthcare trend strengthens demand. Regulatory approvals improve credibility. Urban population growth supports expansion. This drives the highest CAGR growth.

Europe Deep Partial-thickness Thermal Burns Treatment Market Regional Analysis

• The Europe deep partial-thickness thermal burns treatment market is projected to expand at a substantial CAGR throughout the forecast period, primarily driven by a strong public healthcare framework, rising incidence of thermal burn injuries, and increasing adoption of advanced wound care and regenerative treatment solutions across the region. Europe’s emphasis on evidence-based medicine, early burn intervention, and improved patient outcomes is supporting the widespread use of modern burn management technologies
• The growing burden of burn injuries resulting from domestic accidents, industrial activities, and occupational hazards is increasing demand for effective treatment options such as bioengineered skin substitutes, antimicrobial dressings, and advanced wound healing products. In parallel, continuous investments in hospital infrastructure and specialized burn care facilities are enhancing access to high-quality treatment across both urban and semi-urban areas
• In addition, the expansion of dedicated trauma and burn centers, coupled with rising awareness among clinicians regarding optimized burn management protocols, is accelerating the adoption of standardized and advanced treatment solutions for deep partial-thickness thermal burns across Europe

U.K. Deep Partial-thickness Thermal Burns Treatment Market Insight

The U.K. deep partial-thickness thermal burns treatment market dominated the European market with the largest revenue share of approximately 32.4% in 2025, supported by a well-established public healthcare system and the widespread availability of specialized burn units across major hospitals. Strong adoption of advanced wound care products, including bioactive dressings and skin regeneration therapies, is improving healing outcomes and reducing long-term complications. Continuous investments in clinical research, along with the implementation of evidence-based burn management practices within the National Health Service (NHS), are further strengthening the U.K.’s leadership position in the regional market. In addition, a high level of clinician expertise and structured referral pathways for burn patients are ensuring timely and effective treatment delivery.

Germany Deep Partial-thickness Thermal Burns Treatment Market Insight

The deep partial-thickness thermal burns treatment market is expected to be the fastest-growing country in Europe during the forecast period, driven by rising healthcare expenditure and rapid adoption of innovative burn treatment technologies. Germany’s strong focus on advanced medical devices and regenerative medicine is accelerating the uptake of bioengineered skin grafts, collagen-based dressings, and next-generation wound healing solutions. The expansion of trauma centers and specialized burn care facilities, combined with a high level of clinical expertise, is improving treatment accessibility and patient outcomes. Furthermore, Germany’s emphasis on technological innovation and precision medicine is supporting continued advancements in burn treatment protocols, positioning the country as a key growth driver within the European market.

Europe Deep Partial-thickness Thermal Burns Treatment Market Share

The Deep Partial-thickness Thermal Burns Treatment industry is primarily led by well-established companies, including:

• Smith & Nephew (U.K.)
• Mölnlycke Health Care (Sweden)
• 3M Company (U.S.)
• Integra LifeSciences (U.S.)
• ConvaTec Group (U.K.)
• Coloplast (Denmark)
• Medline Industries (U.S.)
• Johnson & Johnson (U.S.)
• B. Braun Melsungen AG (Germany)
• Baxter International (U.S.)
• Cardinal Health (U.S.)
• Derma Sciences (U.S.)
• Paul Hartmann AG (Germany)
• Organogenesis (U.S.)
• Advancis Medical (U.K.)
• Hollister Incorporated (U.S.)
• Medtronic (Ireland)
• Essity AB (Sweden)
• Winner Medical (China)
• Lohmann & Rauscher (Germany)

Latest Developments in Europe Deep Partial-thickness Thermal Burns Treatment Market

• In December 2021, AVITA Medical received FDA approval for RECELL use in pediatric patients with severe thermal burns, broadening the device’s market reach across additional patient populations. This milestone supported greater adoption of regenerative cell-spray technologies in hospitals treating partial-thickness and deep burns
• 2022년 2월, 말린크로트 제약(Mallinckrodt Pharmaceuticals)은 수술적 치료가 필요한 심부 부분층 화상 치료에 승인된 재생 조직 치료제인 스트라타그래프트(StrataGraft)의 지속적인 확장을 발표했습니다. 상용화 및 추가적인 임상 적용을 통해 화상 치료 프로토콜에서 생체공학적 피부 대체재의 활용도가 높아졌습니다.
• 2022년 10월, 인테그라 라이프사이언스는 심각한 화상 재건에 사용되는 인공 피부 기술을 포함한 피부 재생 및 첨단 상처 치료 제품의 임상 적용 범위를 확대하여 심부 진피 및 부분층 화상 관리를 위한 재생 솔루션 분야에서 회사의 입지를 강화했습니다.
• 2023년 6월, 미국 식품의약국(FDA)은 RECELL 자가 세포 채취 장치(AVITA Medical)의 적응증을 확대 승인하여 급성 화상 및 전층 피부 결손 치료에도 사용할 수 있도록 했습니다. 이번 승인 확대를 통해 화상 치료 센터에서 해당 장치의 임상적 적용 가능성이 강화되었으며, 외과의는 치료 현장에서 분무형 피부 세포를 생성할 수 있게 되어 치유 시간을 단축하고 기증자 피부 이식의 필요성을 줄일 수 있게 되었습니다.
• 2024년 3월, AVITA Medical은 화상 환자를 치료하는 의료진의 세포 처리 과정을 표준화하고 워크플로우 효율성을 향상시키도록 설계된 차세대 자동화 장치인 RECELL GO 시스템의 미국 시장 출시를 발표했습니다. 이 시스템은 절차의 일관성을 높여 화상 센터에서 현장 재생 치료법을 더욱 빠르게 도입할 수 있도록 지원합니다.

SKU-65833